Hector Torres-Gomez
Affiliations: | 2014-2016 | Zurich University of Applied Sciences |
Google:
"Hector Torres-Gomez"Mean distance: (not calculated yet)
Parents
Sign in to add mentorJaime Escalante-Garcia | research assistant | 2010-2010 | Universidad Autonoma del Estado de Morelos | |
(Sythesis and enzymatic resolution of beta aminoacids) | ||||
Gabriel Navarrete-Vazquez | grad student | 2007-2009 | Universidad Autonoma del Estado de Morelos | |
(Synthesis of fibrates and thiazolidinediones hybrids) | ||||
Bernhard Wuensch | grad student | 2010-2014 | Westfälische Wilhelms-Universität Münster | |
(Conformationally restricted sigma receptor ligands and epoxide hydrolase inhibitors based on the propellane scaffold) | ||||
Rainer Riedl | post-doc | 2014-2016 | Zurich University of Applied Sciences | |
Florian Kloss | research scientist | 2019- | HKI Jena | |
(Metabolism guided lead optimization. Lead optimization new antibiotics) |
Children
Sign in to add traineePascal Westers | grad student | 2017-2018 | Universität Düsseldorf |
Andrea Seiwert | grad student | 2018-2018 | Universität Düsseldorf |
BETA: Related publications
See more...
Publications
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
Torres-Gómez H, Keiff F, Hortschansky P, et al. (2024) Replacement of the essential nitro group by electrophilic warheads towards nitro-free antimycobacterial benzothiazinones. European Journal of Medicinal Chemistry. 279: 116849 |
Joch M, Wojtas KP, Torres-Gómez H, et al. (2023) Whole cell hydride Meisenheimer complex biotransformation guided optimization of antimycobacterial benzothiazinones. European Journal of Medicinal Chemistry. 264: 116023 |
Burmeister A, Stephan A, Alves Avelar LA, et al. (2022) Establishment and evaluation of a dual HDAC / BET inhibitor as a therapeutic option for germ cell tumors and other urological malignancies. Molecular Cancer Therapeutics |
Colin-Lozano B, Torres-Gomez H, Hidalgo-Figueroa S, et al. (2022) Synthesis, In Vitro, In Vivo and In Silico Antidiabetic Bioassays of 4-Nitro(thio)phenoxyisobutyric Acids Acting as Unexpected PPARγ Modulators: An In Combo Study. Pharmaceuticals (Basel, Switzerland). 15 |
Déciga-Campos M, Melo-Hernández LA, Torres-Gómez H, et al. (2020) Design and synthesis of N‑(benzylpiperidinyl)‑4‑fluorobenzamide: A haloperidol analog that reduces neuropathic nociception via σ receptor antagonism. Life Sciences. 117348 |
Eid SA, Adams M, Scherer T, et al. (2017) Emodin, a compound with putative antidiabetic potential, deteriorates glucose tolerance in rodents. European Journal of Pharmacology |
Navarrete-Vázquez G, Austrich-Olivares A, Godínez-Chaparro B, et al. (2016) Discovery of 2-(3,4-dichlorophenoxy)-N-(2-morpholin-4-ylethyl)acetamide: A selective σ1 receptor ligand with antinociceptive effect. Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie. 79: 284-93 |
Navarrete-Vázquez G, Torres-Gómez H, Hidalgo-Figueroa S, et al. (2014) Synthesis, in vitro and in silico studies of a PPARγ and GLUT-4 modulator with hypoglycemic effect. Bioorganic & Medicinal Chemistry Letters. 24: 4575-9 |
Hernández-Núñez E, Tlahuext H, Moo-Puc R, et al. (2009) Synthesis and in vitro trichomonicidal, giardicidal and amebicidal activity of N-acetamide(sulfonamide)-2-methyl-4-nitro-1H-imidazoles. European Journal of Medicinal Chemistry. 44: 2975-84 |
Navarrete-Vázquez G, Torres-Gómez H, Hidalgo-Figueroa S, et al. (2008) 2-Methyl-2-(4-nitro-phen-oxy)propanoic acid. Acta Crystallographica. Section E, Structure Reports Online. 64: o2261 |